Efficacy and safety of narrowband ultraviolet B versus combined ultraviolet A/narrowband ultraviolet B phototherapy in the treatment of chronic atopic dermatitis: A randomised double‐blind study

Rayson Rui Sheng Lee,Sophie Carrie‐Shan Cai,Yisheng Wong,Yik Weng Yew,Hazel H. Oon,Wei‐Sheng Chong,Hong Liang Tey,Eugene Sern‐Ting Tan
DOI: https://doi.org/10.1111/exd.15012
2024-01-19
Experimental Dermatology
Abstract:Phototherapy is a useful treatment modality for atopic dermatitis (AD). This is a prospective randomised double‐blind study comparing the clinical efficacy of combined ultraviolet‐A (UVA)/narrowband ultraviolet‐B (NBUVB) versus NBUVB phototherapy in the treatment of chronic AD. Patients with moderate‐to‐severe AD were randomised to receive either UVA/NBUVB or NBUVB phototherapy twice weekly over 12 weeks. At baseline, weeks 6 and 12, Eczema Area And Severity Index (EASI), itch score and adverse effects were assessed. At baseline and week 12, disease‐related quality of life was evaluated using the Dermatology Life Quality Index (DLQI). Nine patients were randomised to receive UVA/NBUVB and 10 received NBUVB. At week 12, both groups showed significant improvement in EASI and itch scores (p
dermatology
What problem does this paper attempt to address?